Clinical Trial Update: Study Evaluation Tazocin Intervention [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Tazocin for bacterial infections has completed; Wyeth is now a wholly owned subsidiary of Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Tazocin (piperacillin/tazobactam)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Bacterial Infections | Phase 4 | Status: COMPLETED